---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-021231"
form_type: "8-K"
ticker: "MBOT"
cik: "0000883975"
company_name: "Microbot Medical Inc."
filed_at: "2026-05-05T23:59:59+00:00"
generated_at: "2026-05-14T23:42:01.740048+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Microbot Medical's LIBERTY robotic system adopted by multiple accounts, including pivotal trial sites

## Summary
- LIBERTY Endovascular Robotic System won accounts in key U.S. territories, including two ACCESS-PVI trial sites.
- Company to attend GEST conference in NYC from May 14-17, 2026 to expand commercial footprint.
- Alon Tamir appointed VP of Sales, EMEA to lead international commercialization.
- CEO cites 'strong tailwind post SIR' and expects sustained momentum through peer-to-peer communication.

## SEC filing metadata
- accession: 0001493152-26-021231
- form_type: 8-K
- ticker: MBOT
- cik: 0000883975
- company_name: Microbot Medical Inc.
- filed_at: 2026-05-05T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883975/000149315226021231/0001493152-26-021231-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883975/000149315226021231/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-021231
- JSON: https://secwatch.observer/filing/0001493152-26-021231.json
- Plain text: https://secwatch.observer/filing/0001493152-26-021231.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.